Jorge Navarro Pérez-rekin lankidetzan egindako argitalpenak (13)

2021

  1. Cost of type 2 diabetes patients with chronic kidney disease based on real-world data: An observational population-based study in Spain

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 18

  2. Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort

    Primary Care Diabetes, Vol. 15, Núm. 1, pp. 88-94

2020

  1. The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective study

    Primary Care Diabetes, Vol. 14, Núm. 6, pp. 678-684

2018

  1. Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study (PLoS ONE (2017) 12:10 (e0186196) DOI: 10.1371/journal.pone.0186196)

    PLoS ONE

  2. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: The ESCARVAL-risk study

    BMC Cardiovascular Disorders, Vol. 18, Núm. 1

2017

  1. Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Analysing the concept of diagnostic inertia in hypertension: a cross-sectional study

    International Journal of Clinical Practice, Vol. 70, Núm. 7, pp. 619-624

  2. Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: The ESCARVAL-risk study

    Journal of Hypertension, Vol. 34, Núm. 6, pp. 1075-1083

  3. Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors froma registry-based cohort: The Estudio Cardiovascular Valencia-risk study

    Journal of Hypertension, Vol. 34, Núm. 11, pp. 2266-2273

2014

  1. Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? cross-sectional Escarval study

    PLoS ONE, Vol. 9, Núm. 3

2010

  1. Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

    BMC Public Health, Vol. 10

2004

  1. Indicadores de calidad mínimos para la mejora de la gestión de la hipertensión arterial en Atención Primaria

    Hipertensión y riesgo vascular, Vol. 21, Núm. 3, pp. 100-107

1999

  1. An episode of the prevention of cardiovascular risk factors by age and sex in the Community of Valencia

    Atencion primaria / Sociedad Española de Medicina de Familia y Comunitaria, Vol. 23, Núm. 7, pp. 411-418